secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACCENDRA HEALTH INC/VA/ (ACH)
CIK:        0000075252
Form:       8-K
Filed at:   2026-05-11T23:59:59+00:00
Accession:  0001104659-26-058226
Event type: earnings
Sentiment:  negative
Materiality: 0.85
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Accendra Health Q1 revenue $627.8M, adj. EBITDA $58.4M; >$1.5B debt optimization
--------------------------------------------------------------------------------

- Q1 revenue $627.8M (down 6.8% YoY); GAAP loss from cont. ops $6.5M vs $3.8M loss prior year.
- Adjusted EBITDA $58.4M vs $96.0M prior year; free cash flow ($2.0M).
- Announces comprehensive >$1.5B balance sheet optimization with existing creditors to extend maturities and reduce leverage.
- Transaction expected to pay off 2027 maturities, extend revolver, and reduce total leverage.
- CEO says transformation into pure-play home-based care company on track; Owens & Minor separation proceeding.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/75252/000110465926058226/0001104659-26-058226-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/75252/000110465926058226/ach-20260511x8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-058226

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer